Abvc Biopharma Inc ABVC

$1.01 -0.01 (-0.98%)

Valuation

Market cap
27,228,000
Revenue TTM
$0
Net income TTM
$-7,910,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
98,100
Avg volume
116,882
Day's range
$1.00 – $1.08
Shares out
26,694,000
Stochastic %K
4%
Beta
0.51
Analysts
Strong Buy
Price target
$20.20

Price

Company profile

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for a...

Show more

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus, which is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer; ABV-2001, an intraocular irrigation solution; ABV-2002, a corneal Storage Solution; and ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer. The company has a co-development agreement with Rgene Corporation and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California.

Industry
Biotechnology
Sector
Healthcare
Phone
510 668 0881
Website
https://www.abvcpharma.com
Address
44370 Old Warm Springs Boulevard, Fremont, United States

Latest news

Stocktwits

BigdollarMaker Sep 17, 2:48 PM
$BB $ABVC Oh yeah$$$$
0 replies
BigdollarMaker Sep 16, 4:37 PM
$ABVC Back to $1 now lets get back over
0 replies
BigdollarMaker Sep 4, 2:29 PM
$ABVC We need to get over, this is way too low for what we have!
0 replies
topstockalerts Aug 27, 8:39 PM
$ABVC this one is behaving like it has another chapter.
0 replies
BigdollarMaker Aug 27, 6:14 PM
$BB $ABVC Green feels good.
0 replies
prismmarketview Aug 27, 4:08 PM
PRISM Mid-Day Movers: Healthcare and Consumer Products are Today’s Leaders Biomerica ( $BMRA ) is up 29.59% today to 2.19 from Wednesday’s 1.6899 close. Shares opened at 1.73, traded between 1.71 and 2.33, and volume has surged to 451,115 shares—nearly 39 times its 11,719-share average—signaling exceptionally strong, volatile trading interest in this micro-cap stock. Vince Holding ( $VNCE ) is up 21.45% today to 7.70 from Wednesday’s 6.34 close. The stock opened at 7.50, traded between 7.2981 and 8.08, and volume of 523,567 shares is more than three times its 166,300-share average, reflecting strong buying interest as shares approach their 8.20 52-week high. Other Notable Movers: DeFi Development Corporation ( $DFDV) up 18% ABVC BioPharma ( $ABVC)up 17% Build-A-Bear Workshop ($BBW ) down -27% Stock prices and percentage changes are as of 11:50 p.m. ET on August 27, 2026, and are subject to change. https://prismmarketview.com/prism-mid-day-movers-healthcare-and-consumer-products-are-todays-leaders/
0 replies
Schizoo Aug 13, 8:36 PM
$ABVC 🤌😘
0 replies
Schizoo Aug 13, 2:42 PM
$ABVC swing this!
0 replies